返回 Agenda
Special Session-2 : Consider the Future of the Pharmaceutical Industry. ~What value can DIA Create?
Session Chair(s)
Hideki Oi
Director, Department of Clinical Data Science,
National Center of Neurology and Psychiatry (NCNP), Japan
Keisuke Suzuki, PhD
Director, Innovation Center for Translational Research
National Center for Geriatrics and Gerontology, Japan
Speaker(s)
Issues with the Drug Use-Results Surveys Revealed through a Nationwide Questionnaire Survey of Hospitals and Pharmaceutical Companies
Manabu Hirashima
National Hospital Organization Nagoya Medical Center, Japan
Chief Pharmacist, Clinical Research Center
Status on Post-Marketing Surveillance, after Revision of Good Post-Marketing Study Practice.
Makoto Miyazaki, MSc
Japan Pharmaceutical Manufacturers Association (JPMA) / MSD K.K. , Japan
Megumu Yokono
Waseda University, Japan
Associate Professor of Medical law, School of Social Sciences,
Yumiko Nomura
Ministry of Health, Labour and Welfare (MHLW), Japan
Director, Office of Clinical Trial Promotion
Nao Moriyama
Teikyo University Hospital, Japan
Center for Clinical Research & Trial
Mami Yoshioka
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan
Chief Manager of Clinical trial unit,Healthy Aging Innovation Center